Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.
Clinical trial NCT04358237 · COMPLETED
Trial details
- NCT number
- NCT04358237
- Sponsor
- Antonio Calles Blanco
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2023-09-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.